Adipokines as regulators of muscle metabolism and insulin sensitivity

Applied Physiology, Nutrition and Metabolism

Volumn 34, Issue 3, 2009, Pages 396-402

  Dyck, David J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Adiponectin; Fatty acid metabolism; Fatty acid transport; Leptin; Resistance

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FATTY ACID; GLUCOSE; INSULIN; LEPTIN;

HUMAN; METABOLISM; REVIEW; SKELETAL MUSCLE;

ADIPOKINES; ADIPONECTIN; FATTY ACIDS; GLUCOSE; HUMANS; INSULIN; LEPTIN; MUSCLE, SKELETAL;

EID: 67651216391     PISSN: 17155312     EISSN: None     Source Type: Journal    
DOI: 10.1139/H09-037     Document Type: Review

References (81)

1. Abumrad, N., Harmon, C., and Ibrahimi, A. 1998. Membrane transport of long-chain fatty acids: evidence for a facilitated process. J. Lipid Res. 39(12): 2309-2318. PMID:9831619.
2. Adams, J.M., 2nd, Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R.A., Sullards, M.C., et al. 2004. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes, 53(1): 25-31. doi:10.2337/diabetes.53.1.25. PMID:14693694.
3. Ahren, B., Mansson, S., Gingerich, R.L., and Havel, P.J. 1997. Regulation of plasma leptin in mice: influence of age, high-fat diet, and fasting. Am. J. Physiol. 273: R113-R120. PMID: 9249540.
4. Banks, W.A., and Farrell, C.L. 2003. Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am. J. Physiol. Endocrinol. Metab. 285(1): E10-E15. PMID:12618361.
5. Bonen, A., Luiken, J.J., Liu, S., Dyck, D.J., Kiens, B., Kristiansen, S., et al. 1998. Palmitate transport and fatty acid transporters in red and white muscles. Am. J. Physiol. 275(3 Pt. 1): E471-E478. PMID:9725814.
6. Bonen, A., Parolin, M.L., Steinberg, G.R., Calles-Escandon, J., Tandon, N.N., Glatz, J.F., et al. 2004. Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18(10): 1144-1146. PMID:15132977.
7. Bruce, C.R., Mertz, V.A., Heigenhauser, G.J., and Dyck, D.J. 2005. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes, 54(11): 3154-3160. doi:10.2337/diabetes.54.11.3154. PMID:16249439.
8. Ceddia, R.B., Somwar, R., Maida, A., Fang, X., Bikopoulos, G., and Sweeney, G. 2005. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia, 48(1): 132-139. doi:10.1007/s00125-004-1609-y. PMID:15619075.
9. Chandrasekar, B., Boylston, W.H., Venkatachalam, K., Webster, N.J., Prabhu, S.D., and Valente, A.J. 2008. Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMPK activation and IKK/NF-kappa B/PTEN suppression. J. Biol. Chem. 283: 24889-24898. doi:10.1074/jbc. M804236200. PMID:18632660.
10. Chen, M.B., McAinch, A.J., Macaulay, S.L., Castelli, L.A., O'Brien, P.E., Dixon, J.B., et al. 2005. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J. Clin. Endocrinol. Metab. 90(6): 3665-3672. doi:10.1210/jc. 2004-1980. PMID:15769985.
11. Civitarese, A.E., Jenkinson, C.P., Richardson, D., Bajaj, M., Cusi, K., Kashyap, S., et al. 2004. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes. Diabetologia, 47(5): 816-820. doi:10.1007/s00125-004-1359-x. PMID: 15105989.
12. Civitarese, A.E., Ukropcova, B., Carling, S., Hulver, M., DeFronzo, R.A., Mandarino, L., et al. 2006. Role of adiponectin in human skeletal muscle bioenergetics. Cell Metab. 4(1): 75-87. doi:10.1016/j.cmet.2006.05.002. PMID:16814734.
13. Colombo, C., Cutson, J.J., Yamauchi, T., Vinson, C., Kadowaki, T., Gavrilova, O., et al. 2002. Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy. Diabetes, 51(9): 2727-2733. doi:10.2337/diabetes.51.9.2727. PMID:12196465.
14. Cortright, R.N., Azevedo, J.L., Jr., Zhou, Q., Sinha, M., Pories, W.J., Itani, S.I., et al. 2000. Protein kinase C modulates insulin action in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 278(3): E553-E562. PMID:10710511.
15. Cote, M., Mauriege, P., Bergeron, J., Almeras, N., Tremblay, A., Lemieux, I., et al. 2005. Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. J. Clin. Endocrinol. Metab. 90(3): 1434-1439. doi:10.1210/jc.2004-1711. PMID:15598678.
16. Debard, C., Laville, M., Berbe, V., Loizon, E., Guillet, C., Morio-Liondore, B., et al. 2004. Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients. Diabetologia, 47(5): 917-925. doi:10.1007/s00125-004-1394-7. PMID:15127202.
17. Dobrzyn, A., Knapp, M., and Gorski, J. 2004. Effect of acute exercise and training on metabolism of ceramide in the heart muscle of the rat. Acta Physiol. Scand. 181(3): 313-319. doi:10.1111/j.1365-201X.2004.01295.x. PMID:15196092.
18. Fruebis, J., Tsao, T.S., Javorschi, S., Ebbets-Reed, D., Erickson, M.R., Yen, F.T., et al. 2001. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U.S.A. 98(4): 2005-2010. doi:10.1073/pnas.041591798. PMID:11172066.
19. Gabriely, I., Ma, X.H., Yang, X.M., Rossetti, L., and Barzilai, N. 2002. Leptin resistance during aging is independent of fat mass. Diabetes, 51(4): 1016-1021. doi:10.2337/diabetes.51.4.1016. PMID:11916920.
20. Ghilardi, N., Ziegler, S., Wiestner, A., Stoffel, R., Heim, M., and Radek, S.C. 1996. Defective STAT signalling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 93: 6231-6235. doi:10.1073/pnas.93.13.6231. PMID:8692797.
21. Goodpaster, B.H., Katsiaras, A., and Kelley, D.E. 2003. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes, 52(9): 2191-2197. doi:10.2337/diabetes.52.9.2191. PMID:12941756.
22. Holloway, G.P., Thrush, A.B., Heigenhauser, G.J., Tandon, N.N., Dyck, D.J., Bonen, A., et al. 2007. Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women. Am. J. Physiol. Endocrinol. Metab. 292(6): E1782-E1789. doi:10.1152/ajpendo.00639.2006. PMID: 17311893.
23. Hu, E., Liang, P., and Spiegelman, B.M. 1996. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271(18): 10697-10703. doi:10.1074/jbc.271.18.10697. PMID: 8631877.
24. Hulver, M.W., Berggren, J.R., Cortright, R.N., Dudek, R.W., Thompson, R.P., Pories, W.J., et al. 2003. Skeletal muscle lipid metabolism with obesity. Am. J. Physiol. Endocrinol. Metab. 284(4): E741-E747. PMID:12626325.
25. Hundal, R.S., Krssak, M., Dufour, S., Laurent, D., Lebon, V., Chandramouli, V., et al. 2000. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes, 49(12): 2063-2069. doi:10.2337/diabetes.49.12.2063. PMID:11118008.
26. Itani, S.I., Ruderman, N.B., Schmieder, F., and Boden, G. 2002. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkB-α. Diabetes, 51(7): 2005-2011. doi:10.2337/diabetes.51.7.2005. PMID:12086926.
27. Kellerer, M., Koch, M., Metzinger, E., Mushack, J., Capp, E., and Haring, H.U. 1997. Leptin activates PI-3 kinase in C2C2 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia, 40: 1358-1362. doi:10.1007/s001250050832. PMID:9389430.
28. Kelley, D.E., Goodpaster, B., Wing, R.R., and Simoneau, J.A. 1999. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am. J. Physiol. 277(6 Pt 1): E1130-E1141. PMID:10600804.
29. Kelley, D.E., He, J., Menshikova, E.V., and Ritov, V.B. 2002. Dys-function of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes, 51(10): 2944-2950. doi:10.2337/diabetes.51.10.2944. PMID:12351431.
30. Kim, J.Y., Hickner, R.C., Cortright, R.L., Dohm, G.L., and Houmard, J.A. 2000. Lipid oxidation is reduced in obese human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 279(5): E1039-E1044. PMID:11052958.
31. Kuoppamaa, H., Skrobuk, P., Sihvo, M., Hiukka, A., Chibalin, A.V., Zierath, J.R., et al. 2008. Globular adiponectin stimulates glucose transport in type 2 diabetic muscle. Diabetes Metab. Res. Rev. 24: 554-562. doi:10.1002/dmrr.883. PMID:18615850.
32. Levin, B.E., and Dunn-Meynell, A.A. 2002. Reduced central leptin sensitivity in rats with diet-induced obesity. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283(4): R941-R948. PMID: 12228064.
33. Lin, X., Chavez, M.R., Bruch, R.C., Kilroy, G.E., Simmons, L.A., Lin, L., et al. 1998. The effects of a high fat diet on leptin mRNA, serum leptin and the response to leptin are not altered in a rat strain susceptible to high fat diet-induced obesity. J. Nutr. 128(10): 1606-1613. PMID:9772125.
34. Lonnqvist, F., Arner, P., Nordfors, L., and Schalling, M. 1995. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat. Med. 1(9): 950-953. doi:10.1038/nm0995-950. PMID:7585223.
35. Luiken, J.J., Arumugam, Y., Dyck, D.J., Bell, R.C., Pelsers, M.M., Turcotte, L.P., et al. 2001. Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J. Biol. Chem. 276(44): 40567-40573. doi:10.1074/jbc.M100052200. PMID:11504711.
36. Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., and Matsubara, K. 1996. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 221(2): 286-289. doi:10.1006/bbrc.1996.0587. PMID:8619847.
37. Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., et al. 2002. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 8(7): 731-737. doi:10.1038/nm724. PMID:12068289.
38. Mao, X., Kikani, C.K., Riojas, R.A., Langlais, P., Wang, L., Ramos, F.J., et al. 2006. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell Biol. 8(5): 516-523. doi:10.1038/ncb1404. PMID:16622416.
39. Minokoshi, Y., Kim, Y.B., Peroni, O.D., Fryer, L.G., Muller, C., Carling, D., et al. 2002. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature, 415(6869): 339-343. doi:10.1038/415339a. PMID:11797013.
40. Morris, M.J., Chen, H., Watts, R., Shulkes, A., and Cameron-Smith, D. 2008. Brain neuropeptide Y and CCK and peripheral adipokine receptors: temporal response in obesity induced by palatable diet. Int. J. Obes. (Lond.), 32(2): 249-258. doi:10.1038/sj.ijo.0803716. PMID:17768423.
41. Mullen, K.L., Smith, A.C., Junkin, K.A., and Dyck, D.J. 2007. Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. Am. J. Physiol. Endocrinol. Metab. 293(1): E83-E90. doi:10.1152/ajpendo.00545.2006. PMID:17356008.
42. Mullen, K.L., Pritchard, J., Ritchie, I., Snook, L.A., Chabowski, A., Bonen, A., et al. 2009. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296(2): R243-R251. PMID:19073900.
43. Muoio, D.M., and Lynis Dohm, G. 2002. Peripheral metabolic actions of leptin. Best Pract. Res. Clin. Endocrinol. Metab. 16(4): 653-666. doi:10.1053/beem.2002.0223. PMID:12468413.
44. Muoio, D.M., Dohm, G.L., Fiedorek, F.T., Jr., Tapscott, E.B., and Coleman, R.A. 1997. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes, 46(8): 1360-1363. doi:10.2337/diabetes.46.8.1360. PMID:9231663.
45. Nakano, Y., Tobe, T., Choi-Miura, N.H., Mazda, T., and Tomita, M. 1996. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. 120(4): 803-812. PMID:8947845.
46. Pajvani, U.B., Hawkins, M., Combs, T.P., Rajala, M.W., Doebber, T., Berger, J.P., et al. 2004. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J. Biol. Chem. 279(13): 12152-12162. doi:10.1074/jbc.M311113200. PMID: 14699128.
47. Pan, D.A., Lillioja, S., Kriketos, A.D., Milner, M.R., Baur, L.A., Bogardus, C., et al. 1997. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes, 46(6): 983-988. doi:10.2337/diabetes.46.6.983. PMID:9166669.
48. Petersen, K.F., Oral, E.A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., et al. 2002. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J. Clin. Invest. 109(10): 1345-1350. PMID:12021250.
49. Scarpace, P.J., Matheny, M., Moore, R.L., and Tumer, N. 2000. Impaired leptin responsiveness in aged rats. Diabetes, 49(3): 431-435. doi:10.2337/diabetes.49.3.431. PMID:10868965.
50. Scherer, P.E., Williams, S., Fogliano, M., Baldini, G., and Lodish, H.F. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270(45): 26746-26749. doi:10.1074/jbc.270.45.26746. PMID:7592907.
51. Shimabukuro, M., Koyama, K., Chen, G., Wang, M.Y., Trieu, F., Lee, Y., et al. 1997. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc. Natl. Acad. Sci. U.S.A. 94: 4637-4641. doi:10.1073/pnas.94.9.4637. PMID:9114043.
52. Simoneau, J.A., Veerkamp, J.H., Turcotte, L.P., and Kelley, D.E. 1999. Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J. 13(14): 2051-2060. PMID: 10544188.
53. Singh, M.K., Krisan, A.D., Crain, A.M., Collins, D.E., and Yaspelkis, B.B., 3rd. 2003. High-fat diet and leptin treatment alter skeletal muscle insulin-stimulated phosphatidylinositol 3-kinase activity and glucose transport. Metabolism, 52(9): 1196-1205. doi:10.1016/S0026-0495(03)00158-6. PMID:14506627.
54. Smith, A.C., Bruce, C.R., and Dyck, D.J. 2005. AMP-kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle. J. Physiol. 565: 537-546. doi:10.1113/jphysiol.2004.081679. PMID:15774530.
55. Smith, A.C., Mullen, K.L., Junkin, K.A., Nickerson, J., Chabowski, A., Bonen, A., et al. 2007. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia. Am. J. Physiol. Endocrinol. Metab. 293(1): E172-E181. doi:10.1152/ajpendo.00677.2006. PMID:17374701.
56. Steinberg, G.R., and Dyck, D.J. 2000. Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am. J. Physiol. Endocrinol. Metab. 279(6): E1374-E1382. PMID: 11093926.
57. Steinberg, G.R., Bonen, A., and Dyck, D.J. 2002a. Fatty acid oxidation and triacylglycerol hydrolysis are enhanced after chronic leptin treatment in rats. Am. J. Physiol. Endocrinol. Metab. 282(3): E593-E600. PMID:11832362.
58. Steinberg, G.R., Dyck, D.J., Calles-Escandon, J., Tandon, N.N., Luiken, J.J., Glatz, J.F., et al. 2002b. Chronic leptin administration decreases fatty acid uptake and fatty acid transporters in rat skeletal muscle. J. Biol. Chem. 277(11): 8854-8860. doi:10.1074/jbc.M107683200. PMID:11729182.
59. Steinberg, G.R., Parolin, M.L., Heigenhauser, G.J., and Dyck, D.J. 2002c. Leptin increases FA oxidation in lean but not obese human skeletal muscle: evidence of peripheral leptin resistance. Am. J. Physiol. Endocrinol. Metab. 283(1): E187-E192. PMID: 12067860.
60. Steinberg, G.R., Rush, J.W., and Dyck, D.J. 2003. AMPK expression and phosphorylation are increased in rodent muscle after chronic leptin treatment. Am. J. Physiol. Endocrinol. Metab. 284(3): E648-E654. PMID:12441311.
61. Steinberg, G.R., Smith, A.C., Wormald, S., Malenfant, P., Collier, C., and Dyck, D.J. 2004. Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 286(1): E57-E63. doi:10.1152/ajpendo.00302.2003. PMID:14662513.
62. Steinberg, G.R., McAinch, A.J., Chen, M.B., O'Brien, P.E., Dixon, J.B., Cameron-Smith, D., et al. 2006. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J. Clin. Endocrinol. Metab. 91(9): 3592-3597. doi:10.1210/jc.2006-0638. PMID:16822822.
63. Straczkowski, M., Kowalska, I., Nikolajuk, A., Dzienis-Straczkowska, S., Kinalska, I., Baranowski, M., et al. 2004. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes, 53(5): 1215-1221. doi:10.2337/diabetes.53.5.1215. PMID:15111489.
64. Summers, S.A., Garza, L.A., Zhou, H., and Birnbaum, M.J. 1998. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol. Cell. Biol. 18(9): 5457-5464. PMID:9710629.
65. Sweeney, G. 2002. Leptin signalling. Cell. Signal. 14(8): 655-663. doi:10.1016/S0898-6568(02)00006-2. PMID:12020765.
66. Thrush, A.B., Heigenhauser, G.J., Mullen, K.L., Wright, D.C., and Dyck, D.J. 2008. Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294(4): R1205-R1212. PMID: 18305020.
67. Tomas, E., Tsao, T.S., Saha, A.K., Murrey, H.E., Zhang Cc, C., Itani, S.I., et al. 2002. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U.S.A. 99(25): 16309-16313. doi:10. 1073/pnas.222657499. PMID:12456889.
68. Tsuchida, A., Yamauchi, T., Ito, Y., Hada, Y., Maki, T., Takekawa, S., et al. 2004. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem. 279(29): 30817-30822. doi:10.1074/jbc.M402367200. PMID:15123605.
69. Turcotte, L.P., Swenberger, J.R., Zavitz Tucker, M., and Yee, A.J. 2001. Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats. Diabetes, 50(6): 1389-1396. doi:10.2337/diabetes.50.6.1389. PMID: 11375340.
70. Turner, N., Bruce, C.R., Beale, S.M., Hoehn, K.L., So, T., Rolph, M.S., et al. 2007. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes, 56(8): 2085-2092. doi:10.2337/db07-0093. PMID:17519422.
71. Van Heek, M., Compton, D.S., France, C.F., Tedesco, R.P., Fawzi, A.B., Graziano, M.P., et al. 1997. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest. 99(3): 385-390. doi:10.1172/JCI119171. PMID:9022070.
72. van Loon, L.J., Koopman, R., Manders, R., van der Weegen, W., van Kranenburg, G.P., and Keizer, H.A. 2004. Intramyocellular lipid content in type 2 diabetes patients compared with over-weight sedentary men and highly trained endurance athletes. Am. J. Physiol. Endocrinol. Metab. 287(3): E558-E565. doi:10.1152/ajpendo.00464.2003. PMID:15165998.
73. Waki, H., Yamauchi, T., Kamon, J., Kita, S., Ito, Y., Hada, Y., et al. 2005. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology, 146(2): 790-796. doi:10.1210/en.2004-1096. PMID: 15528304.
74. Wang, J., Obici, S., Morgan, K., Barzilai, N., Feng, Z., and Rossetti, L. 2001. Overfeeding rapidly induces leptin and insulin resistance. Diabetes, 50(12): 2786-2791. doi:10.2337/diabetes.50.12.2786. PMID:11723062.
75. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7(8): 941-946. doi:10.1038/90984. PMID: 11479627.
76. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8(11): 1288-1295. doi:10.1038/nm788. PMID:12368907.
77. Yamauchi, T., Kamon, J., Waki, H., Imai, Y., Shimozawa, N., Hioki, K., et al. 2003. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J. Biol. Chem. 278(4): 2461-2468. doi:10.1074/jbc.M209033200. PMID:12431986.
78. Yaspelkis, B.B., 3rd, Singh, M.K., Krisan, A.D., Collins, D.E., Kwong, C.C., Bernard, J.R., et al. 2004. Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents. Life Sci. 74(14): 1801-1816. doi:10.1016/j.lfs.2003.08.037. PMID:14741737.
79. Yoon, M.J., Lee, G.Y., Chung, J.J., Ahn, Y.H., Hong, S.H., and Kim, J.B. 2006. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes, 55(9): 2562-2570. doi:10.2337/db05-1322. PMID:16936205.
80. Yu, C., Chen, Y., Cline, G.W., Zhang, D., Zong, H., Wang, Y., et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277(52): 50230-50236. doi:10.1074/jbc.M200958200. PMID:12006582.
81. Zhou, Y.T., Shimabukuro, M., Koyama, K., Lee, Y., Wang, M., Trieu, F., et al. 1997. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc. Natl. Acad. Sci. U.S.A. 94: 6386-6390. doi:10.1073/pnas.94.12.6386. PMID: 9177227.